Michael S. Smith's most recent trade in Lamb Weston Holdings Inc was a trade of 3,942 Common Stock done . Disclosure was reported to the exchange on July 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2026 | 3,942 | 144,338 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.50 per share. | 14 Jul 2026 | 2,245 | 142,093 (0%) | 0% | 46.5 | 104,393 | Common Stock |
| Church & Dwight | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 1,238 | 3,029 | - | - | Phantom Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 95.82 per share. | 22 Jun 2026 | 1,806 | 37,648 (0%) | 0% | 95.8 | 173,051 | Common Stock |
| Ulta Beauty | Michael C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 404 | 2,667 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 102.27 per share. | 03 Jun 2026 | 2,159 | 39,454 (0%) | 0% | 102.3 | 220,801 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 108.47 per share. | 22 May 2026 | 6,149 | 41,613 (0%) | 0% | 108.5 | 666,982 | Common Stock |
| Zebra Tech (Class A) | Michael A. Smith | Director | Grant, award, or other acquisition of securities at price $ 247.15 per share. | 19 May 2026 | 951 | 11,646 (0%) | 0% | 247.2 | 235,040 | Class A Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 116.18 per share. | 13 May 2026 | 4,109 | 47,762 (0%) | 0% | 116.2 | 477,384 | Common Stock |
| Church & Dwight | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2026 | 3,060 | 3,060 | - | - | Stock Option (right to buy) | |
| Church & Dwight | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2026 | 920 | 920 (0%) | 0% | 0 | Common Stock | |
| Teledyne Tech | Michael T. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2026 | 319 | 47,647 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 150.98 per share. | 30 Mar 2026 | 19,638 | 51,871 (0%) | 0% | 151.0 | 2,964,945 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2026 | 13,989 | 18,561 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.89 per share. | 30 Mar 2026 | 13,989 | 71,509 (0%) | 0% | 27.9 | 390,153 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2026 | 5,649 | 8,633 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 30 Mar 2026 | 5,649 | 57,520 (0%) | 0% | 17.1 | 96,428 | Common Stock |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 1,616 | 3,232 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2026 | 1,616 | 24,103 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.92 per share. | 12 Mar 2026 | 487 | 23,616 (0%) | 0% | 69.9 | 34,049 | V2X, Inc. Common Stock |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 3,308 | 3,308 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 1,375 | 0 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 1,375 | 22,901 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.85 per share. | 10 Mar 2026 | 414 | 22,487 (0%) | 0% | 71.8 | 29,744 | V2X, Inc. Common Stock |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,744 | 22,051 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 1,744 | 1,744 | - | - | Restricted Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.53 per share. | 06 Mar 2026 | 525 | 21,526 (0%) | 0% | 71.5 | 37,551 | V2X, Inc. Common Stock |
| Tillys Inc (Class A) | Nathan Michael Smith | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2026 | 900,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Tillys Inc (Class A) | Nathan Michael Smith | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Tillys Inc (Class A) | Nathan Michael Smith | Director, See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 26 Feb 2026 | 900,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Tillys Inc (Class A) | Nathan Michael Smith | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2026 | 1,094 | 0 | - | - | Performance Stock Units | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2026 | 1,094 | 20,695 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2026 | 837 | 19,874 (0%) | 0% | - | V2X, Inc. Common Stock | |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.56 per share. | 25 Feb 2026 | 388 | 20,307 (0%) | 0% | 68.6 | 26,603 | V2X, Inc. Common Stock |
| V2X Inc | Michael James Smith | Corp. Dev., IR & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.56 per share. | 25 Feb 2026 | 273 | 19,601 (0%) | 0% | 68.6 | 18,718 | V2X, Inc. Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 24 Feb 2026 | 20,248 | 76,645 (0%) | 0% | 17.1 | 345,633 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2026 | 20,248 | 14,282 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 156.53 per share. | 24 Feb 2026 | 15,771 | 51,871 (0%) | 0% | 156.5 | 2,468,635 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 153.93 per share. | 24 Feb 2026 | 4,852 | 71,793 (0%) | 0% | 153.9 | 746,868 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 155.06 per share. | 24 Feb 2026 | 4,151 | 67,642 (0%) | 0% | 155.1 | 643,654 | Common Stock |
| Teladoc Health Inc | Michael S. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 53,648 | 53,648 | - | - | Restricted Stock Units | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 213,574 | 213,574 | - | - | Employee Stock Option (Right to Buy) | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 213,574 | 213,574 | - | - | Employee Stock Option (Right to Buy) | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 183,063 | 183,063 | - | - | Employee Stock Option (Right to Buy) | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 29,314 | 139,337 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 156.27 per share. | 03 Feb 2026 | 640 | 56,397 (0%) | 0% | 156.3 | 100,013 | Common Stock |
| Teledyne Tech | Michael T. Smith | Director | Sale of securities on an exchange or to another person at price $ 621.00 per share. | 28 Jan 2026 | 2,469 | 47,328 (0%) | 0% | 621 | 1,533,249 | Common Stock |
| Teledyne Tech | Michael T. Smith | Director | Sale of securities on an exchange or to another person at price $ 621.00 per share. | 28 Jan 2026 | 1,531 | 49,797 (0%) | 0% | 621 | 950,751 | Common Stock |
| MillerKnoll Inc | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 7,384 | 27,260 | - | - | Phantom Stock | |
| MillerKnoll Inc | Michael C. Smith | Director | Grant, award, or other acquisition of securities at price $ 19.50 per share. | 15 Jan 2026 | 6,666 | 37,476 (0%) | 0% | 19.5 | 129,987 | Common Stock |
| MillerKnoll Inc | Michael R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.51 per share. | 15 Jan 2026 | 781 | 3,100 (0%) | 0% | 19.5 | 15,235 | Common Stock |
| MillerKnoll Inc | Michael R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 781 | 25,953 | - | - | Phantom Stock | |
| MillerKnoll Inc | Michael R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.50 per share. | 15 Jan 2026 | 526 | 2,319 (0%) | 0% | 19.5 | 10,258 | Common Stock |
| MillerKnoll Inc | Michael R. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 526 | 26,734 | - | - | Phantom Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 173.33 per share. | 06 Jan 2026 | 1,396 | 58,799 (0%) | 0% | 173.3 | 241,969 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 174.17 per share. | 06 Jan 2026 | 1,053 | 57,037 (0%) | 0% | 174.2 | 183,401 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 175.07 per share. | 06 Jan 2026 | 709 | 58,090 (0%) | 0% | 175.1 | 124,125 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 27,600 | 27,600 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 5,293 | 60,195 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.75 per share. | 03 Nov 2025 | 27,130 | 82,032 (0%) | 0% | 23.8 | 644,338 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 27,130 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 181.88 per share. | 03 Nov 2025 | 7,619 | 73,071 (0%) | 0% | 181.9 | 1,385,744 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 182.60 per share. | 03 Nov 2025 | 4,286 | 68,785 (0%) | 0% | 182.6 | 782,624 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 183.92 per share. | 03 Nov 2025 | 4,032 | 64,753 (0%) | 0% | 183.9 | 741,565 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 185.93 per share. | 03 Nov 2025 | 3,636 | 57,874 (0%) | 0% | 185.9 | 676,041 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 184.91 per share. | 03 Nov 2025 | 3,243 | 61,510 (0%) | 0% | 184.9 | 599,663 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 187.15 per share. | 03 Nov 2025 | 1,572 | 56,302 (0%) | 0% | 187.2 | 294,200 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 187.97 per share. | 03 Nov 2025 | 1,400 | 54,902 (0%) | 0% | 188.0 | 263,158 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 181.01 per share. | 03 Nov 2025 | 1,342 | 80,690 (0%) | 0% | 181.0 | 242,915 | Common Stock |
| Tillys Inc (Class A) | Nathan Michael Smith | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2025 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Tillys Inc (Class A) | Nathan Michael Smith | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2025 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Ulta Beauty | Michael C. Smith | Director | Sale of securities on an exchange or to another person at price $ 528.43 per share. | 04 Sep 2025 | 500 | 2,263 (0%) | 0% | 528.4 | 264,215 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 12,780 | 0 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.46 per share. | 02 Sep 2025 | 12,780 | 79,174 (0%) | 0% | 30.5 | 389,279 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 144.16 per share. | 02 Sep 2025 | 8,300 | 61,029 (0%) | 0% | 144.2 | 1,196,528 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 143.16 per share. | 02 Sep 2025 | 7,391 | 69,329 (0%) | 0% | 143.2 | 1,058,096 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 145.18 per share. | 02 Sep 2025 | 4,944 | 56,085 (0%) | 0% | 145.2 | 717,770 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 141.16 per share. | 02 Sep 2025 | 1,354 | 77,820 (0%) | 0% | 141.2 | 191,131 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 145.89 per share. | 02 Sep 2025 | 1,183 | 54,902 (0%) | 0% | 145.9 | 172,588 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 142.06 per share. | 02 Sep 2025 | 1,100 | 76,720 (0%) | 0% | 142.1 | 156,266 | Common Stock |
| Fifth District Bancorp Inc | Shane Michael Smith | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2025 | 11,118 | 18,502 | - | 0 | Common Stock | |
| Fifth District Bancorp Inc | Shane Michael Smith | Chief Credit Officer | 22 Aug 2025 | 11,118 | 18,502 | - | 0 | Common Stock | ||
| Fifth District Bancorp Inc | Shane Michael Smith | Chief Credit Officer | Purchase of securities on an exchange or from another person at price $ 13.45 per share. | 22 Aug 2025 | 2,701 | 7,384 | - | 13.5 | 36,338 | Common Stock |
| Fifth District Bancorp Inc | Shane Michael Smith | Chief Credit Officer | 22 Aug 2025 | 2,701 | 7,384 | - | 13.5 | 36,338 | Common Stock | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.16 per share. | 05 Aug 2025 | 2,211 | 109,389 (0%) | 0% | 53.2 | 117,537 | Common Stock |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.46 per share. | 29 Jul 2025 | 718 | 111,601 (0%) | 0% | 59.5 | 42,692 | Common Stock |
| Teledyne Tech | Michael T. Smith | Director | Sale of securities on an exchange or to another person at price $ 560.10 per share. | 28 Jul 2025 | 1,975 | 51,328 (0%) | 0% | 560.1 | 1,106,198 | Common Stock |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 72,447 | 72,447 | - | - | Employee Stock Option (Right to Buy) | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2025 | 34,505 | 112,319 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 10,687 | 82,289 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Michael Jared Smith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.79 per share. | 15 Jul 2025 | 4,475 | 77,814 (0%) | 0% | 49.8 | 222,810 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 102.51 per share. | 11 Jul 2025 | 933 | 66,394 (0%) | 0% | 102.5 | 95,642 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 96.41 per share. | 11 Jul 2025 | 748 | 67,327 (0%) | 0% | 96.4 | 72,115 | Common Stock |
| Church & Dwight | Michael R. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 1,248 | 1,790 | - | - | Phantom Stock | |
| Ulta Beauty | Michael C. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 383 | 2,763 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 73.50 per share. | 05 Jun 2025 | 1,879 | 67,718 (0%) | 0% | 73.5 | 138,107 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 03 Jun 2025 | 1,448 | 69,597 (0%) | 0% | 71.5 | 103,532 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 70.00 per share. | 30 May 2025 | 20,000 | 71,045 (0%) | 0% | 70 | 1,400,000 | Common Stock |
| Insmed Inc | Michael A. Smith | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 68.56 per share. | 30 May 2025 | 6,327 | 91,045 (0%) | 0% | 68.6 | 433,779 | Common Stock |
| Massimo Grp | Michael Smith | Former Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 25,000 | 50,000 | - | 0 | Common Stock |